Chinese drug maker Akeso, whose new cancer drug has outperformed a leading Western peer in clinical studies, is being hailed ...

Seoul shares got off to a strong start Monday, tracking Wall Street gains, as tech giant Samsung Electronics and other tech ...

How does your work relate to Nigeria’s quest for economic renewal? My work is inspired by the need to contribute to the ...

Zhong Shanshan, China's richest man, made headlines when he briefly overtook Reliance Industries Chairman Mukesh Ambani as ...

South Korean stocks got off to a strong start Monday, tracking Wall Street gains, as tech giant Samsung Electronics and other ...

Nvidia has used its ballooning fortunes to invest in over 80 AI startups. Here are the giant semiconductor's largest ...

Generation Bio (NASDAQ:GBIO – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at Needham & Company LLC in a research note issued to investors on Friday,Benzinga reports. They ...

Viewers of KGTV-TV ABC 10News won’t be seeing some of their familiar anchors and reporters following layoffs initiated by E.W ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection. What will really matter in the long run? That’s the question we tackle each ...

While T-Mobile is proceeding full steam ahead with its direct-to-cell service, a comparable program from AT&T and Verizon has ...

GRNY leverages Millennial spending trends, driving demand for its constituent companies and creating a unique growth moat.

Analyst Brooks Idlet says Accenture's strong balance sheet, diverse customer relationships, and balanced mix of consulting and management services revenues makes the company a high-quality tech ...